CVS Health to hold fourth quarter and full year 2025 earnings conference call

Rhea-AI Summary

CVS Health (NYSE: CVS) will hold a conference call for fourth quarter and full year 2025 financial results on Wednesday, February 11, 2026 at 8:00 a.m. ET.

An audio webcast will be broadcast simultaneously on the company's Investor Relations website at investors.cvshealth.com and will be archived there for one year.

News Market Reaction

-0.37%

1 alert

-0.37% News Effect

On the day this news was published, CVS declined 0.37%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings call date: February 11, 2026 Call time: 8:00 a.m. ET Webcast archive period: 1 year

3 metrics

Earnings call date February 11, 2026 Q4 and full year 2025 earnings conference call

Call time 8:00 a.m. ET Start time for the Q4 and full year 2025 earnings call

Webcast archive period 1 year Duration audio webcast will remain available on Investor Relations site

Market Reality Check

Price: $76.94 Vol: Volume 7,086,838 is at 1....

normal vol

$76.94 Last Close

Volume Volume 7,086,838 is at 1.09x the 20-day average of 6,530,720 shares. normal

Technical Shares at $80.60, trading above 200-day MA of $71.17 and 5.34% below the $85.15 52-week high.

Peers on Argus

Key managed care peers CI, ELV, HUM, CNC, and MOH all showed positive moves toda...

1 Up

Key managed care peers CI, ELV, HUM, CNC, and MOH all showed positive moves today (e.g., MOH up 3.34%, CNC up 1.42%), but momentum scanner flagged only OSCR (up 6.15%) and did not classify this as a broad sector move.

Common Catalyst Multiple health plan peers, including HUM, announced or scheduled Q4 2025 earnings results and calls, pointing to an earnings-date theme across the group.

Historical Context

5 past events · Latest: Jan 06 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 06	Dividend declaration	Positive	+0.3%	Board approved a $0.665 quarterly dividend payable in early February.
Dec 11	Public health initiative	Neutral	+2.4%	Offered MMR vaccines across South Carolina amid a measles outbreak.
Dec 09	Guidance & strategy	Positive	+2.2%	Raised 2025 guidance, issued 2026 outlook, outlined multi-year growth plan.
Dec 05	Economic impact report	Positive	-1.5%	Reported $474B U.S. economic impact and broad national footprint metrics.
Dec 04	Aetna care initiatives	Positive	+2.3%	Expanded prior-authorization simplification and AI-enabled care collaboration.

Pattern Detected

Recent news has mostly seen price gains, with 4 aligned reactions and 1 divergence; one positive strategic/economic update drew a negative response.

Recent Company History

Over the past months, CVS released several notable updates. A $0.665 quarterly dividend for payment on Feb 2, 2026 saw a modest positive reaction. Investor Day on Dec 9, 2025 featured raised 2025 revenue guidance to at least $400.0B and detailed 2026 outlook, which was well received. Operational announcements on measles vaccinations, national economic impact of $474B, and Aetna’s care and AI initiatives also drew mostly positive price responses, framing today’s earnings-call scheduling within a backdrop of active strategic communication.

Market Pulse Summary

This announcement schedules CVS Health’s fourth quarter and full year 2025 earnings conference call ...

Analysis

This announcement schedules CVS Health’s fourth quarter and full year 2025 earnings conference call for February 11, 2026 at 8:00 a.m. ET, with an audio webcast archived for one year. It fits a pattern of regular communication seen in prior quarterly call notices, which historically produced average moves of 2.27%. Investors may watch how these results compare with the updated 2025 and 2026 guidance previously outlined at the company’s 2025 Investor Day.

Key Terms

audio webcast, investor relations

2 terms

audio webcast technical

"An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion"

An audio webcast is a live or recorded audio broadcast transmitted over the internet, allowing listeners to hear presentations, discussions, or updates in real time or on demand. For investors, it provides a way to stay informed about company news, market trends, or industry insights without needing to attend in person, similar to listening to a radio program but accessible from any device.

investor relations financial

"on the Investor Relations portion of the CVS Health website at investors.cvshealth.com"

Investor relations is the communication process between a company and its current or potential investors. It involves sharing information about the company's performance, strategies, and outlook to help investors make informed decisions. Effective investor relations build trust and transparency, similar to a clear conversation between a business and someone considering investing, ensuring both parties understand each other's interests and expectations.

AI-generated analysis. Not financial advice.

WOONSOCKET, R.I., Jan. 9, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11^th, 2026, at 8:00 a.m. ET to discuss fourth quarter and full year 2025 financial results.

An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.

About CVS Health
CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of September 30, 2025, the Company had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics, and a leading pharmacy benefits manager with approximately 87 million plan members. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

Media contact
Ethan Slavin
860-273-6095
SlavinE@cvshealth.com

Investor contact
Larry McGrath
800-201-0938
investorinfo@cvshealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-to-hold-fourth-quarter-and-full-year-2025-earnings-conference-call-302656819.html

SOURCE CVS Health

FAQ

When is CVS (NYSE: CVS) holding its Q4 and full year 2025 earnings call?

The call is scheduled for Wednesday, February 11, 2026 at 8:00 a.m. ET.

How can investors listen to the CVS Q4 and full year 2025 earnings call?

An audio webcast will be broadcast on the Investor Relations site at investors.cvshealth.com.

Will the CVS Health earnings call webcast be available after the live event?

Yes, the audio webcast will be archived for one year on the Investor Relations website.

What topics will CVS (CVS) cover on the February 11, 2026 call?

The call will discuss fourth quarter and full year 2025 financial results.

Is the CVS earnings call on February 11, 2026 open to analysts and investors?

Yes, the company will hold a conference call with analysts and investors.

Where can I find the archived CVS Health earnings call recording after February 11, 2026?

The archived audio will be available at investors.cvshealth.com for one year following the webcast.